CEOi Launches Three Part Podcast Series, “A Breakthrough in Alzheimer’s Diagnostics: Integrating Blood Tests into Clinical Practice” in partnership with Pri-Med

Next
Next

FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease